|
Market Cap | 377.18M | EPS (ttm) | -0.17 |
P/E | - | EPS this Y | 32.38% |
Forward P/E | - | EPS next Y | 50.70% |
PEG | - | EPS past 5Y | 13.81% |
P/S | 2.30 | EPS next 5Y | - |
P/B | 7.64 | EPS Q/Q | 39.27% |
Dividend | - | Sales Q/Q | 23.86% |
Insider Own | 5.15% | Inst Own | 74.53% |
Insider Trans | -3.38% | Inst Trans | -0.34% |
Short Float | 3.26% | Earnings | May 02/a |
Analyst Recom | 1.67 | Target Price | 4.40 |
Avg Volume | 1.57M | 52W Range | 1.21 - 3.08 |
|
|
|
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Shan Hua | Director | May 13 '24 | Buy | 1.99 | 2,500 | 4,975 | 32,386 | May 14 06:30 PM | NACHTSHEIM JAMI K | Director | May 10 '24 | Buy | 1.79 | 2,000 | 3,578 | 108,362 | May 13 05:09 PM | Witney Frank | Director | May 09 '24 | Buy | 1.89 | 20,000 | 37,800 | 180,059 | May 10 08:17 PM | Swisher Daniel N JR | Director | May 09 '24 | Buy | 1.88 | 2,500 | 4,689 | 107,045 | May 09 05:15 PM | Greenman William Mariner | President and CEO | Mar 14 '24 | Sale | 2.02 | 63,611 | 128,195 | 3,181,281 | Mar 14 09:30 PM |
|
|
|
|
Market Cap | 102.52M | EPS (ttm) | -0.09 |
P/E | - | EPS this Y | 92.31% |
Forward P/E | 9.87 | EPS next Y | 120.00% |
PEG | - | EPS past 5Y | -17.87% |
P/S | 0.94 | EPS next 5Y | - |
P/B | 0.64 | EPS Q/Q | -88.69% |
Dividend | 2.58% | Sales Q/Q | 15.22% |
Insider Own | 19.49% | Inst Own | 56.36% |
Insider Trans | 4.35% | Inst Trans | 0.42% |
Short Float | 0.36% | Earnings | Apr 25/b |
Analyst Recom | 3.00 | Target Price | 12.00 |
Avg Volume | 18.35K | 52W Range | 10.03 - 16.12 |
|
|
|
First Northwest Bancorp is a bank holding company which engages in the provision of commercial, mortgage, and lending activities and investment. Its offerings include saving accounts, certificate of deposits, money market, credit cards, fixed rate loans, mortgages, mutual funds, insurances and education savings accounts. The company was founded in 1923 and is headquartered in Port Angeles, WA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Behar Dana D. | Director | May 10 '24 | Buy | 10.50 | 80,000 | 840,000 | 135,467 | May 14 06:20 PM | Terwoerds Lynn | Director | May 01 '24 | Buy | 10.34 | 2,417 | 24,992 | 8,841 | May 01 05:26 PM | Terwoerds Lynn | Director | Mar 11 '24 | Buy | 15.71 | 99 | 1,555 | 6,424 | Mar 13 06:22 PM | DEINES MATTHEW | President / CEO | Mar 07 '24 | Buy | 15.75 | 1,500 | 23,625 | 85,243 | Mar 08 11:46 AM | Zaccardo Jennifer | Director | Mar 07 '24 | Buy | 15.68 | 500 | 7,840 | 38,364 | Mar 08 11:52 AM |
|
|
|
|
Market Cap | 310.05M | EPS (ttm) | -0.89 |
P/E | - | EPS this Y | -11.61% |
Forward P/E | - | EPS next Y | 6.94% |
PEG | - | EPS past 5Y | -70.68% |
P/S | 1.58 | EPS next 5Y | - |
P/B | 2.45 | EPS Q/Q | -31.91% |
Dividend | - | Sales Q/Q | 21.12% |
Insider Own | 26.90% | Inst Own | 65.67% |
Insider Trans | 5.85% | Inst Trans | 10.85% |
Short Float | 6.71% | Earnings | May 07/a |
Analyst Recom | 2.71 | Target Price | 8.42 |
Avg Volume | 810.19K | 52W Range | 3.92 - 27.70 |
|
|
|
Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Treace John T. | Chief Executive Officer | May 14 '24 | Buy | 5.12 | 150,000 | 767,805 | 6,243,095 | May 14 06:19 PM | Kiernan Jane E | Director | May 14 '24 | Buy | 5.17 | 19,356 | 100,001 | 24,941 | May 14 06:20 PM | Treace John T. | Chief Executive Officer | May 13 '24 | Buy | 4.56 | 150,000 | 683,490 | 6,093,095 | May 13 06:07 PM | TREACE JAMES T | Director | May 13 '24 | Buy | 4.54 | 145,000 | 657,981 | 1,039,441 | May 13 07:47 PM | MOTT RICHARD W | Director | May 13 '24 | Buy | 4.38 | 36,802 | 161,090 | 1,027,753 | May 13 07:48 PM |
|
|
| |
|
Market Cap | 838.04M | EPS (ttm) | 0.46 |
P/E | 14.05 | EPS this Y | -20.00% |
Forward P/E | 8.46 | EPS next Y | 18.36% |
PEG | - | EPS past 5Y | - |
P/S | 2.14 | EPS next 5Y | -2.30% |
P/B | 1.30 | EPS Q/Q | -55.01% |
Dividend | 6.86% | Sales Q/Q | -2.53% |
Insider Own | 60.21% | Inst Own | 24.24% |
Insider Trans | 0.07% | Inst Trans | -0.73% |
Short Float | 3.07% | Earnings | May 09/a |
Analyst Recom | 2.00 | Target Price | 8.00 |
Avg Volume | 364.23K | 52W Range | 5.07 - 8.14 |
|
|
|
Granite Ridge Resources, Inc. engages in the exploration, development, and production of oil and natural gas. The company was founded on May 9, 2022 and is headquartered in Dallas, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Brandenberg Luke C | President and CEO | May 14 '24 | Buy | 6.25 | 5,000 | 31,250 | 81,633 | May 14 06:18 PM | Brandenberg Luke C | President and CEO | Mar 15 '24 | Buy | 6.20 | 5,000 | 31,000 | 77,947 | Mar 18 05:35 PM | Farquharson Tyler | Chief Financial Officer | Mar 15 '24 | Buy | 6.20 | 5,000 | 31,000 | 68,037 | Mar 18 07:28 PM | MCCARTNEY JOHN | Director | Mar 15 '24 | Buy | 6.19 | 2,000 | 12,380 | 42,839 | Mar 18 05:27 PM | Miller Matthew Reade | Director | Mar 15 '24 | Buy | 6.22 | 1,650 | 10,263 | 634,057 | Mar 18 06:16 PM |
|
|
|
|
Market Cap | 10.72M | EPS (ttm) | -0.25 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -23.15% |
P/S | 0.61 | EPS next 5Y | - |
P/B | 0.56 | EPS Q/Q | 46.49% |
Dividend | - | Sales Q/Q | 15.44% |
Insider Own | 26.15% | Inst Own | 3.56% |
Insider Trans | 4.81% | Inst Trans | 1.49% |
Short Float | 0.34% | Earnings | May 01/a |
Analyst Recom | 1.00 | Target Price | 1.25 |
Avg Volume | 20.33K | 52W Range | 0.90 - 1.59 |
|
|
|
Socket Mobile, Inc. is a mobile data capture company, which engages in the provision of data capture and delivery solutions for enhanced productivity in workforce mobilization. Its products are incorporated into mobile applications used in point of sale (POS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company's primary products are cordless data capture devices incorporating barcode scanning or RFID/Near Field Communications (NFC) technologies that connect over Bluetooth. All products work with applications running on smartphones, mobile computers and tablets using operating systems from Apple (iOS), Google (Android), and Microsoft (Windows). It also offers an easy-to-use software developer kit (Capture SDK) to application developers, which enables them to provide their users with advanced barcode scanning and RFID/NFC features. The firm's products are integrated in their application solutions and are marketed by the application developers or the resellers of their applications and number of registered developers for data capture applications continues to grow. The company was founded by Michael L. Gifford and Charlie Bass in March 1992 and is headquartered in Fremont, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
BASS CHARLIE | Director | May 14 '24 | Buy | 1.37 | 5,000 | 6,838 | 1,361,651 | May 14 05:31 PM | BASS CHARLIE | Director | May 13 '24 | Buy | 1.30 | 5,000 | 6,511 | 1,356,651 | May 14 05:31 PM | BASS CHARLIE | Director | May 10 '24 | Buy | 1.27 | 5,000 | 6,368 | 1,351,651 | May 10 05:36 PM | BASS CHARLIE | Director | May 09 '24 | Buy | 1.26 | 5,000 | 6,276 | 1,346,651 | May 10 05:36 PM | BASS CHARLIE | Director | May 08 '24 | Buy | 1.24 | 5,000 | 6,206 | 1,341,651 | May 08 05:33 PM |
|
|
| |
|
Market Cap | 401.33M | EPS (ttm) | -15.34 |
P/E | - | EPS this Y | 61.89% |
Forward P/E | - | EPS next Y | 17.24% |
PEG | - | EPS past 5Y | -483.52% |
P/S | - | EPS next 5Y | 25.90% |
P/B | 0.71 | EPS Q/Q | 10.50% |
Dividend | - | Sales Q/Q | - |
Insider Own | 30.15% | Inst Own | 37.35% |
Insider Trans | 15.44% | Inst Trans | -2.70% |
Short Float | 2.65% | Earnings | May 08/a |
Analyst Recom | 1.00 | Target Price | 34.00 |
Avg Volume | 123.40K | 52W Range | 9.91 - 24.59 |
|
|
|
LENZ Therapeutics, Inc. operates as a clinical stage company, which develops ophthalmic pharmaceutical products. It offers eye drop product treatment for presbyopia. The company was founded by James McCollum in July 2013 and is headquartered in Del Mar, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
MCCOLLUM JAMES W | Director | May 13 '24 | Buy | 15.99 | 31,332 | 501,093 | 525,565 | May 14 05:29 PM | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 21 '24 | Buy | 15.03 | 998,009 | 15,000,075 | 3,319,339 | Mar 25 08:48 PM |
|
|
|
|
Market Cap | 257.88M | EPS (ttm) | 0.25 |
P/E | 26.43 | EPS this Y | 30.00% |
Forward P/E | 17.87 | EPS next Y | 15.38% |
PEG | - | EPS past 5Y | 1.15% |
P/S | 1.41 | EPS next 5Y | - |
P/B | 2.27 | EPS Q/Q | 39.55% |
Dividend | - | Sales Q/Q | 35.28% |
Insider Own | - | Inst Own | 64.13% |
Insider Trans | - | Inst Trans | - |
Short Float | 1.30% | Earnings | May 06/a |
Analyst Recom | 1.00 | Target Price | 13.75 |
Avg Volume | 171.50K | 52W Range | 5.90 - 11.08 |
|
|
|
Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. Through its subsidiaries, it supplies home medical equipment which provides post-acute respiratory services. It also offers respiratory disease management and in-home sleep testing and sleep apnea treatment. The company was founded by Casey Hoyt, Max Hoyt, and Michael Moore in 2016 and is headquartered in Lafayette, LA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Heltz Sabrina | Director | May 14 '24 | Buy | 7.08 | 2,820 | 19,977 | 41,040 | May 14 05:25 PM | Smokoff Timothy | Director | Jun 14 '23 | Option Exercise | 2.27 | 10,361 | 23,519 | 77,693 | Jun 15 04:08 PM | Smokoff Timothy | Director | Jun 14 '23 | Sale | 13.51 | 10,361 | 139,977 | 67,332 | Jun 15 04:08 PM |
|
|
| |
|
Market Cap | 61.24M | EPS (ttm) | -0.28 |
P/E | - | EPS this Y | -182.22% |
Forward P/E | - | EPS next Y | 14.96% |
PEG | - | EPS past 5Y | -0.12% |
P/S | 0.09 | EPS next 5Y | 15.00% |
P/B | 0.52 | EPS Q/Q | -733.15% |
Dividend | - | Sales Q/Q | -5.24% |
Insider Own | 5.19% | Inst Own | 75.81% |
Insider Trans | 1.44% | Inst Trans | -0.53% |
Short Float | 7.20% | Earnings | May 07/a |
Analyst Recom | 1.67 | Target Price | 2.33 |
Avg Volume | 816.98K | 52W Range | 0.99 - 5.16 |
|
|
|
CarParts.com, Inc. operates as an online provider of aftermarket auto parts and accessories in the United States and the Philippines. Its products include Collision Parts, Engine Parts, Performance Parts and Accessories. The firm also sells auto parts to collision repair shops, markets Kool-Vue products to auto parts wholesale distributor, and aftermarket catalytic converters under the Evan Fischer brand. Its flagship Websites include www.carparts.com, www.jcwhitney.com, www.autopartswarehouse.com and www.usautoparts.com. The company was founded by Sol Khazani and Mehran Nia in 1995 and is headquartered in Carson, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Lockwood Ryan | Chief Financial Officer | May 12 '24 | Option Exercise | 0.00 | 2,369 | 0 | 80,998 | May 14 05:42 PM | GREYSON JAY KEITH | Director | May 10 '24 | Buy | 1.04 | 41,658 | 43,324 | 282,107 | May 14 05:23 PM | Meniane David | Chief Executive Officer | Apr 18 '24 | Option Exercise | 0.00 | 67,261 | 0 | 1,515,850 | Apr 22 04:21 PM | Lockwood Ryan | Chief Financial Officer | Apr 18 '24 | Option Exercise | 0.00 | 22,254 | 0 | 91,109 | Apr 22 04:24 PM | Subramanian Kals | Chief Technology Officer | Apr 18 '24 | Option Exercise | 0.00 | 16,786 | 0 | 61,994 | Apr 22 04:28 PM |
|
|
|
|
Market Cap | 240.96M | EPS (ttm) | -0.39 |
P/E | - | EPS this Y | -16.58% |
Forward P/E | - | EPS next Y | 45.50% |
PEG | - | EPS past 5Y | - |
P/S | 1.26 | EPS next 5Y | - |
P/B | 9.32 | EPS Q/Q | 48.82% |
Dividend | - | Sales Q/Q | 118.02% |
Insider Own | 6.36% | Inst Own | 45.74% |
Insider Trans | -1.74% | Inst Trans | -1.04% |
Short Float | 32.27% | Earnings | May 07/b |
Analyst Recom | 2.09 | Target Price | 5.43 |
Avg Volume | 3.03M | 52W Range | 1.65 - 5.95 |
|
|
|
EVgo, Inc. engages in the provision of electric vehicle charging station services. It offers the EVgo network, home charging solutions, work charging solutions, and freedom station plans to electric car owners. The company was founded in October 2010 and is headquartered in Los Angeles, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Khan Badar | CEO and Director | May 13 '24 | Buy | 2.01 | 125,000 | 250,750 | 143,874 | May 14 05:18 PM | Sullivan Francine | Chief Legal Officer | Mar 19 '24 | Sale | 2.39 | 1,400 | 3,340 | 88,897 | Mar 19 09:29 PM | Shevorenkova Olga | Chief Financial Officer | Mar 18 '24 | Sale | 2.43 | 750 | 1,824 | 81,241 | Mar 19 09:28 PM | KISH DENNIS G | President | Mar 06 '24 | Sale | 3.00 | 34,717 | 104,151 | 0 | Mar 07 09:47 PM | Shevorenkova Olga | Chief Financial Officer | Mar 06 '24 | Sale | 3.00 | 19,363 | 58,089 | 81,991 | Mar 07 09:48 PM |
|
|
|
|
Market Cap | 1.80B | EPS (ttm) | -0.43 |
P/E | - | EPS this Y | 32.61% |
Forward P/E | - | EPS next Y | 27.42% |
PEG | - | EPS past 5Y | - |
P/S | 8.65 | EPS next 5Y | 31.20% |
P/B | 1.67 | EPS Q/Q | 22.83% |
Dividend | - | Sales Q/Q | -52.98% |
Insider Own | 33.26% | Inst Own | 55.85% |
Insider Trans | -0.60% | Inst Trans | 4.32% |
Short Float | 20.76% | Earnings | May 09/a |
Analyst Recom | 3.43 | Target Price | 1.62 |
Avg Volume | 34.45M | 52W Range | 0.72 - 2.55 |
|
|
|
Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
SLOAN HARRY | Director | May 14 '24 | Buy | 0.91 | 297,619 | 271,815 | 718,540 | May 14 05:16 PM | DEKKERS MARIJN E | Director | May 14 '24 | Sale | 0.93 | 1,727,056 | 1,606,162 | 281,217 | May 14 05:13 PM | Coen Steven P. | See remarks | May 02 '24 | Sale | 0.84 | 131,928 | 111,479 | 162,527 | May 06 04:53 PM | Dmytruk Mark E. | See remarks | May 02 '24 | Sale | 0.84 | 47,806 | 40,396 | 925,400 | May 06 04:55 PM | Dmytruk Mark E. | See remarks | Apr 02 '24 | Sale | 1.05 | 51,169 | 53,727 | 865,079 | Apr 04 04:40 PM |
|
|
|